The Secret Life of O+ Blood

Most of us glance at our blood group on a hospital form — A, B, AB, or O, plus or minus — and think nothing more of it. But that little label is actually a fossil record. It tells a story of ancient plagues, small bands of migrating humans, and one of the strangest genetic detective stories in medicine.

First, what is a blood "type" really?

Your red blood cells are covered in tiny sugar molecules called antigens, sitting on the cell surface like flags. The ABO system depends on one particular sugar structure called the H antigen. Think of the H antigen as the base of a flagpole.

●       If your body adds one extra sugar onto that base, you get the A antigen.

●       A different extra sugar gives you the B antigen.

●       Both together give you AB.

●       And if nothing extra gets added, the flagpole stays bare — that's blood group O.

The "+" or "-" you see (as in O+) refers to a completely separate marker, the Rh factor, another protein on the red cell surface. So O+ simply means: no A or B sugars, but Rh protein present. Roughly 35-38% of people worldwide are O+, making it the single most common blood type on the planet.

Crucially, everyone — A, B, AB, or O — needs that basic H antigen flagpole to be built first. Two genes, called FUT1 and FUT2, are the construction crew that builds it.

Why is O blood so common? A tale of malaria and cholera

Evolution doesn't hand out blood types for no reason — each type spread because it gave some survival edge against the diseases that killed our ancestors. O blood type looks like a textbook case of what biologists call a balanced polymorphism: a trait that helps against one disease while quietly hurting against another, so it never fully takes over the population, but never disappears either.

The reward — malaria resistance. The parasite that causes the deadliest form of malaria, Plasmodium falciparum, hijacks the sugar molecules on red blood cells to help infected cells clump together inside blood vessels, a process called "rosetting." This clumping starves organs of blood flow and drives the severe, often fatal form of the disease. Studies from Mali, Kenya, and Ghana have consistently found that red cells from O-type individuals resist this clumping far better than A, B, or AB cells, so people with O blood are significantly less likely to develop severe, complicated malaria. This is a big part of why blood type O is unusually common across large stretches of malaria-hit Africa and South Asia — it was quite literally a matter of life and death for thousands of years.

The risk — cholera vulnerability. But biology rarely gives you a free lunch. The same O blood type that helps against malaria appears to make people more susceptible to severe, dehydrating cholera, caused by the bacterium Vibrio cholerae. This helps explain a curious geographic pattern: in the cholera-heavy Ganges Delta region spanning Bengal and Bangladesh, blood group B is unusually common and O is comparatively rarer — almost the mirror image of malaria-hit regions. Nature seems to have run two opposite selection pressures on the same gene, pulling populations in different directions depending on which disease mattered more locally.

There's a modern echo of this trade-off too: O blood type has also been linked to somewhat lower rates of blood clots and heart disease, likely because O-type blood carries lower levels of certain clotting factors — handy today, and possibly handy for surviving injuries in our ancestral past as well.

Why O+ people seem to bleed more easily. People with O-type blood carry roughly 25-35% lower levels of a clotting protein called von Willebrand factor (vWF), which helps platelets stick to injured blood vessels and stabilizes another clotting factor (Factor VIII) in the process. The A and B sugar molecules that non-O people carry actually help this clotting protein linger longer in the bloodstream before being broken down; without those sugars, O-type blood clears vWF faster. The practical result: studies on trauma and surgery patients have repeatedly found that people with O blood lose more blood after injury, surgery, or childbirth, and are somewhat overrepresented among people with mild bleeding disorders. It's rarely dangerous on its own, but it's a real, measurable effect — essentially the flip side of the same "thinner," lower-clotting blood that protects O-type people from heart attacks and strokes.

Why mosquitoes seem to prefer O+ people. If you've ever felt like mosquitoes single you out at a barbecue, you may not be imagining it. Multiple studies — going back to a 1974 Oxford study and repeated in more recent lab experiments — have found that mosquitoes land on and feed from people with type O blood more often than those with type A, with type B falling somewhere in between. The likely explanation ties back to the H antigen we discussed earlier: about 85% of people are "secretors," meaning they release small amounts of their blood-type antigens into sweat and saliva, not just their blood. Mosquitoes appear to sniff out these chemical signatures through their antennae, and the H antigen carried by type O secretors seems to be more attractive to them than the A or B antigens. Of course, body heat, breath, sweat chemistry, and carbon dioxide output matter too — blood type is just one ingredient in what makes you a "mosquito magnet."

Why O+ people don't fall sick as easily. Beyond malaria resistance, blood group O has been associated in various studies with lower risk of certain blood clots and severe outcomes in some infections, compared to other blood types — though researchers are still untangling how much of this is due to the ABO genes directly versus other genes that happen to travel alongside them.

The founder effect: when a small group shapes the future

Imagine a large, genetically diverse population. Now imagine a small group breaks away — maybe they migrate to an island, get isolated by mountains, or survive some catastrophe — and that small group becomes the ancestors of an entire new population. Whatever rare genetic quirks that small founding group happened to carry, by pure chance, will now appear at a much higher frequency in their descendants than in the world at large — simply because the "gene pool" they started with was tiny and non-representative.

It's the genetic equivalent of reshuffling a card deck by taking out a random handful of ten cards and only using those to build a family of decks going forward. If that handful happened to have three aces, the new decks will be "unusually" ace-heavy forever after, purely by chance — not because aces were better cards.

Founder effects explain many famous genetic patterns: certain inherited disorders being far more common among the Amish in the US, or among Ashkenazi Jewish and Finnish populations, are classic textbook examples.

The Bombay phenotype: blood type "zero"

In 1952, doctors in Bombay (now Mumbai) encountered something baffling. A patient's blood reacted as if it were type O when tested one way, but violently attacked type O blood in another test — something that should have been medically impossible. This led to the discovery of what's now called the Bombay phenotype, or hh blood group.

Remember the H antigen "flagpole" we talked about earlier? It turns out that building it at all requires a working copy of the FUT1 gene. Most of us have at least one working copy. But a very small number of people inherit two broken copies — one from each parent — and so they cannot build the H antigen flagpole in the first place. Without the base structure, it doesn't matter whether their genes would otherwise make A-sugars or B-sugars; there's simply no flagpole for those sugars to attach to. Their red cells look completely bare, more "empty" than even ordinary type O.

This has serious real-world consequences. People with the Bombay phenotype produce antibodies against the H antigen itself — meaning their immune system will attack any blood that isn't also Bombay type, including regular type O blood, which is otherwise considered the "universal donor" safe for almost everyone. In an emergency, a Bombay-phenotype patient can only safely receive blood from another Bombay-phenotype donor. It is one of the rarest and most transfusion-restrictive blood profiles known to medicine.

And here's where the founder effect returns to center stage: the Bombay phenotype is extraordinarily rare worldwide — roughly 1 in a million people in Europe — but occurs far more frequently in parts of India, especially Maharashtra and other southern and western regions, with estimates around 1 in 10,000 in Mumbai, and even higher concentrations in some tribal communities such as the Bhuyan population of Odisha. This geographic clustering is a hallmark of a founder effect.